JILLIAN F PATTON

Allopathic & Osteopathic Physicians|Family Medicine FLORESVILLE, TX NPI 1801324124

General Payments — all program years on this page

$1,796.06

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 106
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $422.51 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $422.5121

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $189.008
ABBVIE INC. $73.664
PFIZER INC. $70.134
Acerta Pharma LLC $36.692
Merck Sharp & Dohme Corporation $19.741
GlaxoSmithKline, LLC. $16.921
Astellas Pharma US Inc $16.371

By program year

Program yearAmountRecords
2020 $17.071
2021 $190.1012
2022 $611.3537
2023 $555.0335
2024 $422.5121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104300608 AstraZeneca Pharmaceuticals LP $18.93 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105213538 ABBVIE INC. $21.02 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105213542 ABBVIE INC. $17.79 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105213546 ABBVIE INC. $20.07 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105213550 ABBVIE INC. $14.78 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105890310 AstraZeneca Pharmaceuticals LP $17.76 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116592362 GlaxoSmithKline, LLC. $16.92 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131134815 PFIZER INC. $16.77 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131650939 PFIZER INC. $19.60 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131851045 PFIZER INC. $14.76 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132006806 PFIZER INC. $19.00 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135023998 Lilly USA, LLC $22.14 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135047872 Lilly USA, LLC $20.14 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135047874 Lilly USA, LLC $19.86 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135064229 Lilly USA, LLC $16.77 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135064231 Lilly USA, LLC $29.10 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135064437 Lilly USA, LLC $29.62 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135066971 Lilly USA, LLC $30.36 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135066973 Lilly USA, LLC $21.01 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139263128 Astellas Pharma US Inc $16.37 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141706884 Merck Sharp & Dohme LLC $19.74 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.